Search Results for: Diabetes

3097 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
HNF4A and PCBD1 hepatocyte nuclear factor 4, alpha pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Phenylalanine and tyrosine catabolism
  • Metabolism of amino acids and derivatives
HNF4A and TRIM24 hepatocyte nuclear factor 4, alpha tripartite motif containing 24
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Signaling by FGFR in disease
  • Signaling by FGFR1 mutants
  • Signaling by FGFR mutants
  • Signaling by FGFR1 fusion mutants
HNF4A and COPS5 hepatocyte nuclear factor 4, alpha COP9 signalosome subunit 5
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and ZNHIT3 hepatocyte nuclear factor 4, alpha zinc finger, HIT-type containing 3
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and NR0B2 hepatocyte nuclear factor 4, alpha nuclear receptor subfamily 0, group B, member 2
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and NR2F1 hepatocyte nuclear factor 4, alpha nuclear receptor subfamily 2, group F, member 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and NR1I3 hepatocyte nuclear factor 4, alpha nuclear receptor subfamily 1, group I, member 3
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
HNF4A and SIRT1 hepatocyte nuclear factor 4, alpha sirtuin 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Epigenetic regulation of gene expression
  • Negative epigenetic regulation of rRNA expression
  • SIRT1 negatively regulates rRNA Expression
  • Cellular response to heat stress
  • Regulation of HSF1-mediated heat shock response
HNF4A and TP53 hepatocyte nuclear factor 4, alpha tumor protein p53
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
HNF4A and SMAD2 hepatocyte nuclear factor 4, alpha SMAD family member 2
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
HNF4A and SMAD3 hepatocyte nuclear factor 4, alpha SMAD family member 3
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
HNF4A and SMAD4 hepatocyte nuclear factor 4, alpha SMAD family member 4
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by BMP
  • Transcriptional regulation of pluripotent stem cells
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
HNF4A and RNF4 hepatocyte nuclear factor 4, alpha ring finger protein 4
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
HNF4A and TGS1 hepatocyte nuclear factor 4, alpha trimethylguanosine synthase 1
  • Generic Transcription Pathway
  • Nuclear Receptor transcription pathway
  • PPARA activates gene expression
  • Organelle biogenesis and maintenance
  • Fatty acid, triacylglycerol, and ketone body metabolism
  • Metabolism of lipids and lipoproteins
  • Metabolism of non-coding RNA
  • REV-ERBA represses gene expression
  • RORA activates circadian gene expression
  • Mitochondrial biogenesis
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Generic Transcription Pathway
  • snRNP Assembly
  • Transcriptional regulation of white adipocyte differentiation
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • Activation of gene expression by SREBF (SREBP)
  • Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
  • Transcriptional activation of mitochondrial biogenesis
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • Orphan transporters
HNRNPD and IGF2BP2 heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) insulin-like growth factor 2 mRNA binding protein 2
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • mRNA Splicing - Major Pathway
  • Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
HSPA5 and MTNR1B heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) melatonin receptor 1B
  • Platelet degranulation
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • ATF6-alpha activates chaperone genes
  • IRE1alpha activates chaperones
  • Response to elevated platelet cytosolic Ca2+
  • Class I MHC mediated antigen processing & presentation
  • Platelet activation, signaling and aggregation
  • ATF6-alpha activates chaperones
  • PERK regulates gene expression
  • Unfolded Protein Response (UPR)
  • Adaptive Immune System
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (i) signalling events
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Antihemophilic Factor
  • Ramelteon
  • Melatonin
  • Agomelatine
HSPB1 and INS heat shock 27kDa protein 1 insulin
  • Regulation of mRNA stability by proteins that bind AU-rich elements
  • Signaling by VEGF
  • AUF1 (hnRNP D0) destabilizes mRNA
  • VEGFA-VEGFR2 Pathway
  • Synthesis, secretion, and deacylation of Ghrelin
  • Insulin receptor signalling cascade
  • Integration of energy metabolism
  • Regulation of insulin secretion
  • IRS-related events
  • SHC-related events
  • Insulin receptor recycling
  • Peptide hormone metabolism
  • IRS activation
  • Regulation of beta-cell development
  • Signal attenuation
  • Regulation of gene expression in beta cells
  • Insulin processing
  • SHC activation
  • Signaling by Insulin receptor
ICAM1 and IL2RA intercellular adhesion molecule 1 interleukin 2 receptor, alpha
  • Interferon gamma signaling
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Integrin cell surface interactions
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Adaptive Immune System
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • GPCR downstream signaling
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Natalizumab
  • Hyaluronan
  • Denileukin diftitox
  • Aldesleukin
  • Basiliximab
  • Daclizumab
ICAM3 and PRKCQ intercellular adhesion molecule 3 protein kinase C, theta
  • Integrin cell surface interactions
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Signaling by GPCR
  • Downstream TCR signaling
  • Axon guidance
  • Effects of PIP2 hydrolysis
  • FCERI mediated NF-kB activation
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • The phototransduction cascade
  • Programmed Cell Death
  • G alpha (z) signalling events
  • Netrin-1 signaling
  • Innate Immune System
  • Apoptotic cleavage of cellular proteins
  • Apoptotic execution phase
  • Diseases associated with visual transduction
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • TCR signaling
  • Visual phototransduction
  • Fc epsilon receptor (FCERI) signaling
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Staurosporine
  • Phosphonothreonine
  • Phosphonoserine
IFNA1 and IL2 interferon, alpha 1 interleukin 2
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Regulation of IFNA signaling
  • Interferon Signaling
  • TRAF6 mediated IRF7 activation
  • Cytokine Signaling in Immune system
  • Interferon alpha/beta signaling
  • Factors involved in megakaryocyte development and platelet production
  • Innate Immune System
  • Signaling by GPCR
  • G-protein beta:gamma signalling
  • Cytokine Signaling in Immune system
  • Signaling by Interleukins
  • GPCR downstream signaling
  • Interleukin receptor SHC signaling
  • G beta:gamma signalling through PI3Kgamma
  • Interleukin receptor SHC signaling
  • GPVI-mediated activation cascade
  • Interleukin-2 signaling
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • SP4160
  • 5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid
  • 3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One
  • (R)-N-[2-[1-(Aminoiminomethyl)-3-Piperidinyl]-1-Oxoethyl]-4-(Phenylethynyl)-L-Phenylalanine Methylester
  • (1h-Indol-3-Yl)-(2-Mercapto-Ethoxyimino)-Acetic Acid
  • SP2456
  • 2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide

Page 20 out of 155 pages